In addition to its anti‐inflammatory effects, SGK1 inhibition in glia potentiates the neuroprotective functions of glia and prevents glial cell senescence, which has recently been reported as a critical pathologic feature of and therapeutic target in AD and PD (Bussian et al, 2018; Chinta et al, 2018). This evidence concerns the gene SGK1 and Parkinson disease.